How I treat older patients with AML
- 1 September 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 96 (5) , 1670-1673
- https://doi.org/10.1182/blood.v96.5.1670
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Randomized Phase II Study of Fludarabine + Cytosine Arabinoside + Idarubicin ± All-Trans Retinoic Acid ± Granulocyte Colony-Stimulating Factor in Poor Prognosis Newly Diagnosed Acute Myeloid Leukemia and Myelodysplastic SyndromeBlood, 1999
- Implications of Potential Cure in Acute Myelogenous Leukemia: Development of Subsequent Cancer and Return to WorkBlood, 1997
- Treatment of newly‐diagnosed acute myelogenous leukaemia in patients aged 80 years and aboveBritish Journal of Haematology, 1996
- Validation of a model to predict survival in elderly patients with acute myeloid leukaemiaBritish Journal of Haematology, 1995
- Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995
- Intensive Postremission Chemotherapy in Adults with Acute Myeloid LeukemiaNew England Journal of Medicine, 1994
- Prognostic Factors in Elderly Patients with Acute Myeloid LeukaemiaLeukemia & Lymphoma, 1994
- Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patientsBritish Journal of Haematology, 1994
- On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group.Journal of Clinical Oncology, 1989
- Smoldering Acute Granulocytic LeukemiaArchives of internal medicine (1960), 1983